Browsing: Advances

CINCINNATI (WKRC) – A Cincinnati-based company that began more than 25 years ago is helping drive medical research aimed at giving patients more options while prioritizing safety

As the global obesity drug market shifts its competitive focus from “how much weight patients lose” to “how well the effect holds with fewer injections,” South Korean pharmaceutical and biotech firms are also making progress on long-acting formulations that sharply cut the number of doses required

This is a paid press release. Contact the press release distributor directly with any enquiries.

South Korea, Aug. 14, 2026 /PRNewswire/ — SK bioscience announced that it has submitted a Clinical Trial Application (CTA) to the South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive antibody candidate licensed from the Gates Medical Research Institute (Gates MRI),…

Dark Horse, a planned health and fitness facility from ESPN analyst and former college and pro basketball player Steffi Sorensen, has taken its first steps into St. Johns County’s development review process, paving the way for the project team to submit a building permit application

Neurocrine Biosciences (Nasdaq: NBIX) has dosed the first participants in a Phase I first-in-human study of NBIP-1968, an internally discovered glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)/glucagon receptor triple agonist for obesity. The study evaluates single ascending doses in adults across a range of body mass index categories, with safety and tolerability as the primary endpoint.…

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

A Senate committee on Thursday advanced Dr. Erica Schwartz’s nomination to be director of the nation’s top public health agency, setting aside concerns that she will not stand up to political meddling

A Senate committee on Thursday advanced Dr. Erica Schwartz’s nomination to be director of the nation’s top public health agency, setting aside concerns that she will not stand up to political meddling

For most of history, dementia was not common. The likelihood of developing the disease increases with age, and people in the past typically didn’t live well into their senior years